메뉴 건너뛰기




Volumn 42, Issue 3, 2014, Pages

Catatonia in the ICU: An important and underdiagnosed cause of altered mental status. A case series and review of the literature

Author keywords

antipsychotic agents; benzodiazepines; catatonia; critical care; delirium; dopamine antagonists; encephalopathy; neuroleptic malignant syndrome; psychiatry

Indexed keywords

ADOLESCENT; AGED; ANTI-ANXIETY AGENTS; BLOOD CHEMICAL ANALYSIS; CATATONIA; CRITICAL ILLNESS; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENSIVE CARE UNITS; LORAZEPAM; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84894435671     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000053     Document Type: Review
Times cited : (51)

References (34)
  • 1
    • 0029916688 scopus 로고    scopus 로고
    • Catatonia I Rating scale and standardized examination
    • Bush G, Fink M, Petrides G, et al: Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand 1996; 93:129-136
    • (1996) Acta Psychiatr Scand , vol.93 , pp. 129-136
    • Bush, G.1    Fink, M.2    Petrides, G.3
  • 2
    • 0042978721 scopus 로고    scopus 로고
    • Catatonia in psychiatric classification: A home of its own
    • Taylor MA, Fink M: Catatonia in psychiatric classification: A home of its own. Am J Psychiatry 2003; 160:1233-1241
    • (2003) Am J Psychiatry , vol.160 , pp. 1233-1241
    • Taylor, M.A.1    Fink, M.2
  • 3
    • 73549121544 scopus 로고    scopus 로고
    • Catatonia: Clinical aspects and neurobiological correlates
    • Daniels J: Catatonia: Clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci 2009; 21:371-380
    • (2009) J Neuropsychiatry Clin Neurosci , vol.21 , pp. 371-380
    • Daniels, J.1
  • 4
    • 13744257761 scopus 로고    scopus 로고
    • Catatonia is a risk factor for neuroleptic malignant syndrome
    • Carroll BT, Lee JW: Catatonia is a risk factor for neuroleptic malignant syndrome. J Clin Psychiatry 2004; 65:1722-1723
    • (2004) J Clin Psychiatry , vol.65 , pp. 1722-1723
    • Carroll, B.T.1    Lee, J.W.2
  • 6
    • 0042026401 scopus 로고    scopus 로고
    • What catatonia can tell us abouttop-down modulation: A neuropsychiatric hypothesis
    • discussion 578-604
    • Northoff G: What catatonia can tell us about top-down modulation: A neuropsychiatric hypothesis. Behav Brain Sci 2002; 25:555-577; discussion 578-604
    • (2002) Behav Brain Sci , vol.25 , pp. 555-577
    • Northoff, G.1
  • 7
    • 23044519146 scopus 로고    scopus 로고
    • Catatonia, lethal catatonia, and neuroleptic malignant syndrome
    • Fricchione G, Mann SC, Caroff SN: Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatr Ann 2000; 30:347-355
    • (2000) Psychiatr Ann , vol.30 , pp. 347-355
    • Fricchione, G.1    Mann, S.C.2    Caroff, S.N.3
  • 8
    • 0033188198 scopus 로고    scopus 로고
    • Delirious mania
    • Fink M: Delirious mania. Bipolar Disord 1999; 1:54-60
    • (1999) Bipolar Disord , vol.1 , pp. 54-60
    • Fink, M.1
  • 10
    • 0030974191 scopus 로고    scopus 로고
    • Recognition and treatment of the catatonic syndrome
    • Fricchione G, Bush G, Fozdar M, et al: Recognition and treatment of the catatonic syndrome. J Intensive Care Med 1997; 12:135-147
    • (1997) J Intensive Care Med , vol.12 , pp. 135-147
    • Fricchione, G.1    Bush, G.2    Fozdar, M.3
  • 12
    • 73549121544 scopus 로고    scopus 로고
    • Catatonia: Clinical aspects and neurobiological correlates
    • Daniels J: Catatonia: Clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci 2009; 21:371-380
    • (2009) J Neuropsychiatry Clin Neurosci , vol.21 , pp. 371-380
    • Daniels, J.1
  • 13
    • 0030070128 scopus 로고    scopus 로고
    • Neuroleptic malignant syndrome and catatonia: One entity or two?
    • Fink M: Neuroleptic malignant syndrome and catatonia: One entity or two? Biol Psychiatry 1996; 39:1-4
    • (1996) Biol Psychiatry , vol.39 , pp. 1-4
    • Fink, M.1
  • 14
    • 70350644890 scopus 로고    scopus 로고
    • The catatonia syndrome: Forgotten but not gone
    • Fink M, Taylor MA: The catatonia syndrome: Forgotten but not gone. Arch Gen Psychiatry 2009; 66:1173-1177
    • (2009) Arch Gen Psychiatry , vol.66 , pp. 1173-1177
    • Fink, M.1    Taylor, M.A.2
  • 16
    • 84894421836 scopus 로고    scopus 로고
    • In Textbook of Psychsomatic Medicine: Psychiatric Care of the Medically Ill . Second Edition. Levenson J (Ed). Washington, DC, American Psychiatric Publishing
    • Freudenreich O, Nejad SH, Francis A, et al: Psychosis, mania, and catatonia. In: Textbook of Psychsomatic Medicine: Psychiatric Care of the Medically Ill. Second Edition. Levenson J (Ed). Washington, DC, American Psychiatric Publishing, 2011, pp 219-240
    • (2011) Psychosis, Mania, and Catatonia , pp. 219-240
    • Freudenreich, O.1    Nejad, S.H.2    Francis, A.3
  • 17
    • 0029995097 scopus 로고    scopus 로고
    • Catatonia. II. Treatment with lorazepam and electroconvulsive therapy
    • Bush G, Fink M, Petrides G, et al: Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93:137-143
    • (1996) Acta Psychiatr Scand , vol.93 , pp. 137-143
    • Bush, G.1    Fink, M.2    Petrides, G.3
  • 19
    • 63849282626 scopus 로고    scopus 로고
    • Medical evaluation of patients undergoing electroconvulsive therapy
    • Tess AV, Smetana GW: Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med 2009; 360:1437-1444
    • (2009) N Engl J Med , vol.360 , pp. 1437-1444
    • Tess, A.V.1    Smetana, G.W.2
  • 21
    • 33644851831 scopus 로고    scopus 로고
    • Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients
    • Pandharipande P, Shintani A, Peterson J, et al: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104:21-26
    • (2006) Anesthesiology , vol.104 , pp. 21-26
    • Pandharipande, P.1    Shintani, A.2    Peterson, J.3
  • 22
    • 0032854692 scopus 로고    scopus 로고
    • Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal
    • Kanemoto K, Miyamoto T, Abe R: Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Seizure 1999; 8:364-366
    • (1999) Seizure , vol.8 , pp. 364-366
    • Kanemoto, K.1    Miyamoto, T.2    Abe, R.3
  • 23
    • 0031027811 scopus 로고    scopus 로고
    • Catatonia associated with lorazepam withdrawal
    • Glover SG, Escalona R, Bishop J, et al: Catatonia associated with lorazepam withdrawal. Psychosomatics 1997; 38:148-150
    • (1997) Psychosomatics , vol.38 , pp. 148-150
    • Glover, S.G.1    Escalona, R.2    Bishop, J.3
  • 24
    • 0035142918 scopus 로고    scopus 로고
    • Benzodiazepine withdrawal-induced catatonia
    • Deuschle M, Lederbogen F: Benzodiazepine withdrawal-induced catatonia. Pharmacopsychiatry 2001; 34:41-42
    • (2001) Pharmacopsychiatry , vol.34 , pp. 41-42
    • Deuschle, M.1    Lederbogen, F.2
  • 26
    • 80051729813 scopus 로고    scopus 로고
    • Memantine and catatonia: A case report and literature review
    • Obregon DF, Velasco RM, Wuerz TP, et al: Memantine and catatonia: A case report and literature review. J Psychiatr Pract 2011, 17:292-299
    • (2011) J Psychiatr Pract , vol.17 , pp. 292-299
    • Obregon, D.F.1    Velasco, R.M.2    Wuerz, T.P.3
  • 27
    • 0030954175 scopus 로고    scopus 로고
    • Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine
    • Northoff G, Eckert J, Fritze J: Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997; 62:404-406
    • (1997) J Neurol Neurosurg Psychiatry , vol.62 , pp. 404-406
    • Northoff, G.1    Eckert, J.2    Fritze, J.3
  • 28
    • 0036161124 scopus 로고    scopus 로고
    • Valproate for catatonia: Need for caution in patients on SSRIs and antipsychotics
    • Lauterbach EC: Valproate for catatonia: need for caution in patients on SSRIs and antipsychotics. J Neuropsychiatry Clin Neurosci 2002; 14:84-86
    • (2002) J Neuropsychiatry Clin Neurosci , vol.14 , pp. 84-86
    • Lauterbach, E.C.1
  • 29
    • 0026545505 scopus 로고
    • ECT response in catatonia
    • Francis A, Fink M: ECT response in catatonia. Am J Psychiatry 1992; 149:581-582
    • (1992) Am J Psychiatry , vol.149 , pp. 581-582
    • Francis, A.1    Fink, M.2
  • 31
    • 0035082268 scopus 로고    scopus 로고
    • ECT for prolonged catatonia
    • Malur C, Pasol E, Francis A: ECT for prolonged catatonia. J ECT 2001; 17:55-59
    • (2001) J ECT , vol.17 , pp. 55-59
    • Malur, C.1    Pasol, E.2    Francis, A.3
  • 32
    • 10344260661 scopus 로고    scopus 로고
    • Malignant catatonia/neuroleptic malignant syndrome or how to change the view on ECT
    • Plesnicar BK, But MF, Zalar B: Malignant catatonia/neuroleptic malignant syndrome or how to change the view on ECT. J ECT 2004; 20:273
    • (2004) J ECT , vol.20 , pp. 273
    • Plesnicar, B.K.1    But, M.F.2    Zalar, B.3
  • 33
    • 34250791330 scopus 로고    scopus 로고
    • Successful ECT course for catatonia after large pulmonary embolus and placement of inferior vena cava filter
    • Tsao C, Nusbaum A: Successful ECT course for catatonia after large pulmonary embolus and placement of inferior vena cava filter. Gen Hosp Psychiatry 2007; 29:374
    • (2007) Gen Hosp Psychiatry , vol.29 , pp. 374
    • Tsao, C.1    Nusbaum, A.2
  • 34
    • 40449109728 scopus 로고    scopus 로고
    • Encephalitis and catatonia treated with ECT
    • Ali S, Welch CA, Park LT, et al: Encephalitis and catatonia treated with ECT. Cogn Behav Neurol 2008; 21:46-51
    • (2008) Cogn Behav Neurol , vol.21 , pp. 46-51
    • Ali, S.1    Welch, C.A.2    Park, L.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.